Page last updated: 2024-08-18

pyrazolanthrone and Lymphoma, Mantle-Cell

pyrazolanthrone has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atayar, C; Bosga-Bouwer, A; Kluin, P; Rosati, S; Visser, L; Wang, M	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Lymphoma, Mantle-Cell

Article	Year
JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125. The Journal of pathology, 2009, Volume: 218, Issue:1 Topics: Anthracenes; Apoptosis; Case-Control Studies; Cell Cycle; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Mantle-Cell; Palatine Tonsil; Polyploidy; Proto-Oncogene Proteins c-bcl-2; Thiazoles	2009

Article

Year

JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125.

The Journal of pathology, 2009, Volume: 218, Issue:1

Topics: Anthracenes; Apoptosis; Case-Control Studies; Cell Cycle; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Mantle-Cell; Palatine Tonsil; Polyploidy; Proto-Oncogene Proteins c-bcl-2; Thiazoles

2009